Commonwealth Equity Services’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42K | Buy |
19,248
+7,094
| +58% | +$15.5K | ﹤0.01% | 4167 |
|
|
2025
Q1 | $13K | Buy |
12,154
+100
| +0.8% | +$107 | ﹤0.01% | 4142 |
|
|
2024
Q4 | $13K | Sell |
12,054
-3,500
| -23% | -$3.78K | ﹤0.01% | 4060 |
|
|
2024
Q3 | $19K | Hold |
15,554
| – | – | ﹤0.01% | 4003 |
|
|
2024
Q2 | $19K | Buy |
15,554
+1,500
| +11% | +$1.83K | ﹤0.01% | 3975 |
|
|
2024
Q1 | $14K | Buy |
14,054
+1,640
| +13% | +$1.63K | ﹤0.01% | 3976 |
|
|
2023
Q4 | $13K | Hold |
12,414
| – | – | ﹤0.01% | 3848 |
|
|
2023
Q3 | $20K | Hold |
12,414
| – | – | ﹤0.01% | 3735 |
|
|
2023
Q2 | $19K | Buy |
+12,414
| New | +$19K | ﹤0.01% | 3753 |
|
|
2018
Q1 | – | Sell |
-25
| Closed | -$10K | – | 2771 |
|
|
2017
Q4 | $10K | Buy |
+25
| New | +$10K | ﹤0.01% | 2666 |
|